Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 1/2003

01-04-2003

Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey

Authors: Hiroki Kawai, Atsushi Ohtsu, Narikazu Boku, Yasuo Hamamoto, Fumio Nagashima, Manabu Muto, Yasushi Sano, Kiyomi Mera, Tomonori Yano, Toshihiko Doi, Shigeaki Yoshida

Published in: Gastric Cancer | Special Issue 1/2003

Login to get access
Metadata
Title
Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey
Authors
Hiroki Kawai
Atsushi Ohtsu
Narikazu Boku
Yasuo Hamamoto
Fumio Nagashima
Manabu Muto
Yasushi Sano
Kiyomi Mera
Tomonori Yano
Toshihiko Doi
Shigeaki Yoshida
Publication date
01-04-2003
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue Special Issue 1/2003
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-003-0216-9

Other articles of this Special Issue 1/2003

Gastric Cancer 1/2003 Go to the issue

OriginalPaper

Longterm control of advanced and recurrent gastric cancer (ARGC) by S-1

OriginalPaper

Neoadjuvant chemotherapy with S-1 for scirrhous gastric cancer: a pilot study

OriginalPaper

Future prospects of personalized chemotherapy in gastric cancer patients: results of a prospective randomized pilot study

OriginalPaper

Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer

OriginalPaper

A new regimen for S-1 therapy aiming at adverse reaction mitigation and prolonged medication by introducing a 1-week drug-free interval after each 2-week dosing session: efficacy and feasibility in clinical practice

Review article

S-1 in gastric cancer: a comprehensive review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits